Virtu Financial’s Aerie Pharmaceuticals AERI Stock Holding History

Virtu Financial’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-25,101	Closed	-$380K	–	2560
2022 Q3	$380K	Buy	+25,101	New	+$292K	0.03%	536
2022 Q1	–	Sell	-13,155	Closed	-$92K	–	2385
2021 Q4	$92K	Buy	+13,155	New	+$138K	0.01%	1168
2021 Q3	–	Sell	-13,778	Closed	-$221K	–	2213
2021 Q2	$221K	Buy	+13,778	New	+$236K	0.02%	931
2019 Q3	–	Sell	-8,427	Closed	-$249K	–	1973
2019 Q2	$249K	Buy	+8,427	New	+$325K	0.01%	898
2018 Q3	–	Sell	-4,709	Closed	-$318K	–	2387
2018 Q2	$318K	Buy	+4,709	New	+$263K	0.02%	1112

Virtu Financial's AERI Position: Q4 2022 in Review

Virtu Financial sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 25,101 shares — an estimated $380K sold.

Virtu Financial first reported a position in AERI in Q2 2018 and held it in 5 quarters. The position peaked at $380K in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

Virtu Financial reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Virtu Financial sold 25,101 Aerie Pharmaceuticals shares in Q4 2022, an estimated $380K.
Virtu Financial first reported a position in Aerie Pharmaceuticals in Q2 2018 and held it in 5 quarters.
Virtu Financial's Aerie Pharmaceuticals position peaked at $380K in Q3 2022.
0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Virtu Financial's 13F filing for Q4 2022, filed 15 Feb 2023.